Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

Share Price Information for Apax Global Alpha (APAX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 149.00
Bid: 148.00
Ask: 149.00
Change: -1.00 (-0.67%)
Spread: 1.00 (0.676%)
Open: 146.40
High: 149.00
Low: 146.40
Prev. Close: 150.00
APAX Live PriceLast checked at -
Apax Global Alpha is an Investment Trust

To provide shareholders with capital appreciation from our investment portfolio and regular dividends.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

8 Mar 2016 07:00

RNS Number : 3270R
Apax Global Alpha Limited
08 March 2016
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR WITHIN THE UNITED STATES OR TO "US PERSONS" (AS DEFINED IN REGULATION S UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT")) OR INTO OR WITHIN AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN. RECIPIENTS OF THIS ANNOUNCEMENT IN JURISDICTIONS OUTSIDE THE UK SHOULD INFORM THEMSELVES ABOUT AND OBSERVE ANY APPLICABLE LEGAL REQUIREMENTS IN THEIR JURISDICTIONS. IN PARTICULAR, THE DISTRIBUTION OF THE ANNOUNCEMENT MAY BE RESTRICTED BY LAW IN CERTAIN JURISDICTIONS.

Note that references in this announcement to Apax Global Alpha Limited have been abbreviated to "AGA" or "the Company". References to Apax Partners LLP have been abbreviated to "Apax Partners" or "the Investment Adviser"

FOR IMMEDIATE RELEASE

8 March 2016

(LSE: APAX)

Apax Global Alpha Limited

Audited Results for the period ended 31 December 2015

 

The financial statements cover the period from 2 March 2015 to 31 December 2015. Where we discuss the trading period to 31 December 2014 this refers to the period as PCV Lux S.C.A ("PCV") and its subsidiaries (collectively the "PCV Group") prior to the acquisition by AGA. Irrespective of whether the text refers to AGA or PCV, references to the trading period from 1 January to 31 December 2015 include trading as PCV prior to the transfer of assets to AGA following the acquisition and listing on 15 June 2015.

 

For further information regarding the announcement of AGA's 2015 Annual Reports and Accounts, including the details for today's analyst and investor call at 9.30am (UK time), please visit www.apaxglobalalpha.com/investor-information/calendar

 

Financial highlights for the twelve months to 31 December 2015

· Adjusted NAV, (i.e. NAV excluding performance fee reserves), increased by €110.7m to €923.6m due to investment performance, equivalent to a Total Return of 13.6%

· Adjusted NAV per share is €1.88 (equivalent to £1.38 at 31 December 2015), up from €1.66 pro-forma at 31 December 2014

· First semi-annual dividend announced of 3.69 pence per share, equivalent to 2.5% of NAV at 31 December 2015

· The IPO raised the maximum targeted gross proceeds of €300m(1) and was over-subscribed

· AGA was 98% invested at 31 December 2015 and had a cash balance of €22.9m(2)

 

Investment highlights for twelve months to 31 December 2015

· Well balanced invested portfolio: Private Equity (52%) and Derived Investments (48%)

· Sector exposure is balanced across all Apax Partners' focus industries. As at 31 December 2015, Services is the sector with the strongest weight, accounting for 31% of the invested portfolio

· Geographic bias towards North America representing 57% of the invested portfolio at 31 December 2015

 

Operational performance

· Strong investment fundamentals both in Private Equity and Derived Investments, showing resilience and robust trading throughout 2015:

 

Private Equity - Quarterly Operational Metrics

31 December 2014

31 December 2015

Portfolio year-over-year Last Twelve Months (LTM) revenue growth(3)

14.4%

7.8%

Portfolio year-over-year LTM EBITDA growth(3)

11.8%

9.0%

Average EV/EBITDA multiple(3)

11.3x

12.4x

Average net debt / EBITDA(3)

4.9x

4.6x

Number of new investments(4)

4

13

Number of exits(4)

6

10

 

Derived Investments - Quarterly Operational Metrics

31 December 2014

31 December 2015

YTM(5) of debt investments

9.7%

11.5%

Average years to maturity for debt investments (in years)

6.7

6.1

Average income yield(6) of debt investments

8.0%

9.6%

Year-over-year LTM EBITDA growth debt investments(7)

9.3%

5.0%

Year-over-year LTM earnings growth equity investments(8)

8.7%

14.8%

Average P/E multiple(9) of equity investments

19.9x

20.0x

Number of new investments(10)

23

16

Number of full exits(11)

5

8

 

· The Investment Manager has highlighted the following in Private Equity portfolio

o Apax Private Equity funds are exploiting strong exit markets and have returned €24.6m to AGA since 31 December 2014

o Apax Private Equity funds made 13 new investments in 2015, thereof 11 new investments by Apax VIII and two by AMI

 

· The Investment Manager has highlighted the following in Derived Investments

o Fully exited four debt investments and five listed equity investments, realising total proceeds of €125.4m. In addition, partial realisations totalled proceeds of €1.0m.

o In the 12 months to 31 December 2015, AGA made ten new investments in debt, two add-ons to current debt positions and four new investments in listed equities totalling €249.1m in the year to 31 December 2015.

 

Commenting on the results, Tim Breedon CBE, Chairman of Apax Global Alpha, said:

"I am delighted to present our first annual results since the Company's successful move on to the London Stock Exchange in June 2015, and to announce the payment of our first semi-annual dividend to shareholders.

"It has been an excellent first year as a public company; AGA successfully raised €300m(1) from its IPO and has made strong progress in investing the proceeds, by contributing to Apax private equity funds and investing in other asset classes derived from Apax's private equity activities. In line with our strategy, we recently announced our intention to commit US$350m to the Apax IX private equity fund and have fully realised our last legacy hedge fund investments.

"Our portfolio has performed well and we have seen a nearly 14% rise in Adjusted NAV and Adjusted NAV per share. This is an excellent result in what have been difficult markets and AGA's portfolio has outperformed all relevant benchmark indices.

"With the increased volatility in the markets, new interesting investment opportunities arise. AGA will continue to exploit value opportunities, including those opened up by market dislocations. We look forward with confidence to the year ahead."

Commenting on AGA's investment focus, Ralf Gruss, COO of Apax Partners, said:

"AGA's Invested Portfolio is split evenly, with 52% in Private Equity and 48% in Derived Investments. The strong performance of the portfolio was achieved despite more volatile conditions across our markets during the second half of 2015.

"Over the past year, the investment focus has been on deploying the net proceeds raised from the Initial Public Offering into both Private Equity and Derived Investments. Markets offer interesting investment opportunities for AGA following recent corrections and the ability of AGA to exploit opportunities across different sectors, geographies, and asset classes is predestined to benefit from a continuation of the more volatile market environment."

 

Financial highlights

Private Equity

 

 

€m

Derived Investments

 

 

€m

Cash and Legacy Hedge Funds

€m

Others

 

 

 

€m

Total

 

 

 

€m

NAV as at 31 December 2014

198.8

294.8

38.7

4.9

537.2

+ Net IPO proceeds

-

-

275.0

-

275.0

+ Investments

211.1

249.1

(460.2)

-

-

- Divestments

(24.6)

(117.2)

143.8

-

2.0

+ Interest and dividend income

-

-

23.2

-

23.2

+/- Unrealised gains

82.8

(9.0)

-

-

73.8

+/- FX gains

5.5

23.4

4.4

-

33.3

+/- Costs and others

(2.0)

(6.0)

(8.0)

NAV as of 31 December 2015

473.6

441.1

22.9

(1.1)

936.5

+/- Change in performance fee reserve

(4.2)

(8.7)

-

-

(12.9)

Adjusted NAV as of 31 December 2015

469.4

432.4

22.9

(1.1)

923.6

 

Invested portfolio analysis at 31 December 2015

Asset class

(excluding hedge funds)

 

€m

 

€m

 

%

 

%

Private Equity

473.6

52

- AEVI

6.5

1

- AE VII

87.1

9

- AE VIII

376.5

41

- AMI

3.5

1

Derived Investments

441.1

48

- Debt

346.7

38

- Equities

94.4

10

Total

914.7

914.7

100

100

 

Sector mix

 

 

€m

Portfolio

 

%

Private Equity

 

%

Derived Investments

%

Tech & Telco

259.9

28

31

26

Services

286.1

31

35

27

Consumer

224.2

25

21

28

Healthcare

133.3

15

11

18

Other

11.2

1

2

1

Total

914.7

100

100

100

 

Geographic analysis

 

 

€m

Portfolio

 

%

Private Equity

 

%

Derived Investments

%

North America

523.3

57

51

64

UK

46.6

5

6

4

Switzerland

14.2

1

0

3

Rest of Europe

206.4

23

32

12

India

83.4

9

7

12

China

26.1

3

1

5

RoW

14.7

2

3

0

Total

914.7

100

100

100

 

Summary of top 10 investments in Private Equity and Derived Investments

Valuation

€m

% of NAV

% of invested portfolio

Top 10 Private Equity

 EVRY ASA

43.5

5

5

 GlobalLogic Inc

37.8

4

4

 Assured Partners

28.8

3

3

 Azelis S.A.

28.4

3

3

 Exact Software

27.8

3

3

 Full Beauty

25.3

3

3

 One Call / Align

24.6

3

3

 Garda

23.1

2

3

 Wehkamp

21.3

2

2

 Answers Corporation

15.6

2

2

Other

197.4

21

22

Total Private Equity

473.6

51

52

 

 

 

 

Top 10 Derived Investments

 

 

 

 Full Beauty

31.4

3

3

 Assured Partners

30.8

3

3

 Exact Software

25.4

3

3

 Epicor

21.2

2

2

 Compuware

20.7

2

2

 Azelis Finance

19.6

2

2

 Genex

19.1

2

2

 Rue21 Inc

19.0

2

2

 Acelity (Kinetic Concepts)

18.1

2

2

 Answers Corporation

17.9

2

2

 Other

217.9

23

24

Total Derived Investments

441.1

47

48

 

 

 

 

Total Investments

914.7

98

100

Cash

22.9(4)

2

0

Net current assets

(1.1)

0

0

Total NAV

936.5

100

0

 

Contact details

Investor Relations

Sarah Wojcik

Telephone:

+44 (0)20 7872 6300

Email:

investor.relations@apaxglobalalpha.com

 

 

Media enquiries (Apax Global Alpha Limited)

Georgiana Brunner/Matthew Goodman/Annabel Clay, Greenbrook Communications

Telephone:

+44 (0)20 7952 2000

Email:

aga@greenbrookpr.com

 

 

Media enquiries (Apax Partners LLP)

Alex Wessendorff

Telephone:

+44 (0)20 7872 6461

Email:

alex.wessendorff@apax.com

 

 

Company Secretary

Matt Horton/Jacques Colley, Aztec Group

Telephone:

+44 (0)1481 749 700

Email:

AGA-Admin@aztecgroup.co.uk

 

Notes

 

1. The information presented herein is not an offer for sale within the United States of any equity shares or other securities of Apax Global Alpha Limited ("AGA"). AGA has not been and will not be registered under the US Investment Company Act of 1940, as amended (the "Investment Company Act"). In addition, AGA's shares (the "Shares") have not been and will not be registered under the Securities Act or any other applicable law of the United States. Consequently, the Shares may not be offered or sold or otherwise transferred within the United States, or to, or for the account or benefit of, US Persons, except pursuant to an exemption from the registration requirements of the Securities Act and under circumstances which will not require AGA to register under the Investment Company Act. No public offering of the Shares is being made in the United States.

2. This announcement may include forward-looking statements. The words "expect", "anticipate", "intends", "plan", "estimate", "aim", "forecast", "project" and similar expressions (or their negative) identify certain of these forward-looking statements. These forward-looking statements are statements regarding AGA's intentions, beliefs or current expectations concerning, among other things, AGA's results of operations, financial condition, liquidity, prospects, growth and strategies. The forward-looking statements in this presentation are based on numerous assumptions regarding AGA's present and future business strategies and the environment in which AGA will operate in the future. Forward-looking statements involve inherent known and unknown risks, uncertainties and contingencies because they relate to events and depend on circumstances that may or may not occur in the future and may cause the actual results, performance or achievements of AGA to be materially different from those expressed or implied by such forward looking statements. Many of these risks and uncertainties relate to factors that are beyond AGA's ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behaviour of other market participants, the actions of regulators and other factors such as AGA's ability to continue to obtain financing to meet its liquidity needs, changes in the political, social and regulatory framework in which AGA operates or in economic or technological trends or conditions. Past performance should not be taken as an indication or guarantee of future results, and no representation or warranty, express or implied, is made regarding future performance. AGA expressly disclaims any obligation or undertaking to release any updates or revisions to these forward-looking statements to reflect any change in AGA's expectations with regard thereto or any change in events, conditions or circumstances on which any statement is based after the date of this announcement, or to update or to keep current any other information contained in this announcement. Accordingly, undue reliance should not be placed on the forward-looking statements, which speak only as of the date of this announcement.

Footnotes

(1) Total proceeds of €300m were raised based on the FX rate at the date of allocation prior to IPO. A total of €301.4m was raised when the proceeds were recalculated to euro based on the exchange rate at close of business on the date of listing the 15 June 2015.

 

(2) Comprises €21.5m held in AGA directly and €1.4m held in subsidiaries.

 

(3) Represents the weighted average of the respective metrics across the underlying portfolio companies, using latest available information.

 

(4) Represents investments and exits during the year ending at the indicated date. Note that the 13 new investments during 2015 excludes the additional AEVII stake acquired by AGA during 2015. In addition the 10 exits during 2015 includes 6 full exits and 4 significant partial exits

 

(5) GAV weighted average yield to maturity (YTM) of the Derived Debt Investments

 

(6) GAV weighted average of the current full year income (annual coupon/clean price as at 31 December 2015) for each debt position in the Derived Debt Investments at 31 December 2015

 

(7) GAV weighted average of latest available EBITDA growth, since prior year, of the underlying Derived Debt Investments

 

(8) GAV weighted average of the latest earnings growth, since prior year, of the underlying Derived Equity Investments

 

(9) GAV weighted Price Earnings multiple of Derived Equity Investments

 

(10) New investments in debt in 2015 were 2 positions in Azelis, Epicor, 2 positions in Exact Holdings, Physiotherapy, Genex, Synlab, Quality Distribution, Assured Partners, Full Beauty, Rue 21 and new equity positions in Hinduja Global Solutions, Sinopharm, Cinda Asset Management and LIC Holdings.

(11) Disposals in 2015 consisted of debt realisations in Auto Trader, Apax Europe VII Co-invest facility, Synlab and Azelis and full equity realisations in KPIT, China Rundong, Telecity and HDFC.

 

About Apax Global Alpha Ltd

AGA is a Guernsey closed-ended investment company that listed on the London Stock Exchange on 15th June 2015.

AGA's objective is to provide shareholders with capital appreciation from its investment portfolio and regular dividends. The Company is targeting an annualised Total Return across economic cycles of 12-15% (net of fees and expenses) including a dividend yield of 5% of Net Asset Value (NAV), once fully invested.

The investment policy of the Company is to make private equity investments in Apax Funds and Derived Investments which are investments in equities and debt derived from the insights gained via Apax Partners' Private Equity activities. The Company's portfolio is expected to be allocated in approximately equal proportions between Private Equity and Derived Investments, although the investment mix will fluctuate over time due to market conditions, investment opportunities, cashflow requirements, the dividend policy and other factors.

About Apax Partners LLP

 

Apax Partners LLP ("Apax Partners") is a leading global private equity advisory firm. It operates globally and has more than 30 years of investing experience. Apax Partners has advised funds that total over €34 billion in aggregate as at 31 December 2015. Funds advised by Apax Partners invest in companies across four global sectors of Tech & Telco, Services, Healthcare and Consumer. These funds provide long‐term equity financing to build and strengthen world‐class companies. For further information about Apax Partners, please visit www.apax.com.

 

Apax Partners LLP is authorised and regulated by the Financial Conduct Authority in the UK.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR SSLEDWFMSEED
Date   Source Headline
2nd May 20247:00 amRNSAudit Committee Change
2nd May 20247:00 amRNSResult of AGM
2nd May 20247:00 amRNSQuarterly Results to 31 March 2024
24th Apr 20247:00 amRNSApax Funds to acquire IANS
18th Apr 20247:00 amRNSApax Funds To Acquire Zellis Group
5th Apr 20249:58 amRNSDirector/PDMR Shareholding
4th Apr 20242:02 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSNotice of Capital Markets Day
22nd Mar 202410:08 amRNSHolding in Company
11th Mar 20245:17 pmRNSPurchase of Ordinary Shares under IMA
5th Mar 20247:00 amRNS2023 Annual Dividend Declaration
5th Mar 20247:00 amRNSNotice of AGM
5th Mar 20247:00 amRNS2023 Annual Report and Accounts
5th Mar 20247:00 amRNS2023 Final Results
1st Mar 20242:00 pmRNSRetirement of Chris Ambler from the Board
28th Feb 20247:00 amRNSApax Funds Acquire IES
8th Feb 20247:00 amRNSEstimated Adjusted NAV as at 31 December 2023
2nd Feb 20247:00 amRNSApax Funds Acquire WGSN
4th Dec 20233:00 pmEQSHardman & Co Q&A on Apax Global Alpha: Hidden gems strategy delivering new investment opportunities
23rd Nov 202312:43 pmEQSHardman & Co Research on Apax Global Alpha (APAX): “Hidden Gems” strategy: green shoots into live deals
17th Nov 202312:58 pmRNSDirector/PDMR Shareholding
15th Nov 20237:00 amRNSApax Funds Invest in Petvisor
9th Nov 20237:00 amRNSQuarterly Results to 30 September 2023
27th Oct 20237:00 amRNSApax Funds Acquire GAN Integrity
12th Oct 20232:15 pmEQSHardman & Co Q&A on Apax Global Alpha (APAX): Confirming strong underlying competitive advantages
11th Oct 20237:00 amRNSApax Funds acquire Bazooka Candy Brands
5th Oct 20237:00 amRNSNotice of Q3 2023 Financial Results
2nd Oct 20237:00 amRNSDirectorate Change
25th Sep 20235:06 pmRNSHolding in Company
25th Sep 20232:45 pmEQSHardman & Co Research on Apax Global Alpha (APAX): Resilience in face of rising interest rates
12th Sep 202311:30 amRNSDirector/PDMR Shareholding
6th Sep 20237:02 amRNS2023 Interim Dividend
6th Sep 20237:01 amRNS2023 Interim Report and Accounts
6th Sep 20237:00 amRNS2023 Interim Results Highlights
7th Aug 20237:00 amRNSEstimated Adjusted NAV as at 30 June 2023
1st Aug 20237:00 amRNSFunds advised by Apax to acquire Palex
20th Jul 20234:35 pmEQSHardman & Co Q&A on Apax Global Alpha (APAX) Capital Markets Day: value added by the manager
5th Jul 20233:50 pmEQSHardman & Co Research on Apax Global Alpha (APAX) 2023 Capital Markets Day: accessing hidden gems
2nd Jun 20237:00 amRNSFunds advised by Apax invest in Swing Education
23rd May 20237:00 amRNSNotice of Capital Markets Day
16th May 20237:00 amRNSFunds advised by Apax to acquire IBS Software
4th May 20237:00 amRNSResult of AGM
4th May 20237:00 amRNSQuarterly results for 31 March 2023
21st Mar 20232:05 pmEQSHardman & Co Q&A on Apax Global Alpha (APAX): 2022 results adding value to companies leads to outperformance
14th Mar 20232:05 pmEQSHardman & Co Research on Apax Global Alpha (APAX): Outperformance by adding value to companies
13th Mar 20237:00 amRNSUpdate relating to SVB
2nd Mar 20237:00 amRNS2022 Annual Dividend Declaration
2nd Mar 20237:00 amRNSNotice of AGM
2nd Mar 20237:00 amRNS2022 Annual Report and Accounts
2nd Mar 20237:00 amRNS2022 Final Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.